v3.22.2.2
Segment Information
12 Months Ended
Jun. 30, 2022
Segment Information

Note 12. Segment Information

We have one operating segment which is the development of pharmaceutical compounds. All of our assets and liabilities were located in the U.S. as of June 30, 2022 and 2021.